4.8 Article

A metagenomic study of the gut microbiome in Behcet's disease

Journal

MICROBIOME
Volume 6, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s40168-018-0520-6

Keywords

Behcet's disease; Gut microbiome; Metagenomic analysis; Fecal microbiota transplant

Categories

Funding

  1. National Key R&D Program of China [2016YFC0904000]
  2. Natural Science Foundation Major International (Regional) Joint Research Project [81720108009]
  3. National Natural Science Foundation [81700826, 31670118, 81301475, 81770916, 81470620, 81770914]
  4. Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]
  5. Chongqing Science and Technology Platform and Base Construction Program [cstc2014pt-sy10002]
  6. Natural Science Foundation of Zhejiang Province [LR15H030002]
  7. Natural Science Foundation Project of Chongqing [cstc2017shmsA130073]
  8. Chongqing applied basic research projects and cutting-edge technology [cstc2016jcyjA1196]
  9. Research fund for Traditional Chinese Medicine of Chongqing Health and Family Planning Commission [ZY20141013]

Ask authors/readers for more resources

Background: Behcet's disease (BD) is a recalcitrant, multisystemic inflammatory disease that can lead to irreversible blindness. Microbial agents have been considered to contribute to the pathogenesis of this disease, but the underlying mechanisms remain unclear. In this study, we investigated the association of gut microbiome composition with BD as well as its possible roles in the development of this disease. Methods: Fecal and saliva samples were collected from 32 active BD patients and 74 healthy controls. DNA extracted from fecal samples was subjected to metagenomic analysis, whereas DNA extracted from saliva samples was subjected to 16S rRNA gene sequencing analysis. The results were used to compare the composition and biological function of the microbiome between patients and healthy controls. Lastly, transplantation of pooled fecal samples from active BD patients into B10RIII mice undergoing experimental autoimmune uveitis (EAU) was performed to determine the causal relationship between the gut microbiome and BD. Results: Fecal samples from active BD patients were shown to be enriched in Bilophila spp., a sulfate-reducing bacteria (SRB) and several opportunistic pathogens (e.g., Parabacteroides spp. and Paraprevotella spp.) along with a lower level of butyrate-producing bacteria (BPB) Clostridium spp. and methanogens (Methanoculleus spp. Methanomethylophilus spp.). Analysis of microbial functions revealed that capsular polysaccharide transport system, oxidation-reduction process, type III, and type IV secretion systems were also increased in active BD patients. Network analysis showed that the BD-enriched SRB and opportunistic pathogens were positively correlated with each other, but they were negatively associated with the BPB and methanogens. Animal experiments revealed that fecal microbiota transplantation with feces from BD patients significantly exacerbated EAU activity and increased the production of inflammatory cytokines including IL-17 and IFN-gamma. Conclusions: Our findings revealed that BD is associated with considerable gut microbiome changes, which is corroborated by a mouse study of fecal microbiota transplants. A model explaining the association of the gut microbiome composition with BD pathogenesis is proposed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available